Glycologix develops locally delivered biopolymers that mimic natural proteoglycans to protect and repair soft tissues, with a focus on interstitial cystitis and bladder pain syndrome. Their technology addresses significant unmet medical needs in soft tissue indications, providing a targeted therapeutic approach for large patient populations.
Funding
$6.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Interstitial cystitis/bladder pain syndrome (IC/BPS) lacks effective treatments, leaving many patients with chronic pain and urinary dysfunction. Current therapies often provide limited relief and can have significant side effects. There is a need for targeted therapies that can protect and repair the bladder lining.
Solution
Glycologix is developing locally delivered biopolymers that mimic natural proteoglycans to protect and repair soft tissues, specifically targeting IC/BPS. Their lead compound, GLX-100, is designed to adhere to bladder tissues and provide a protective barrier, promoting tissue repair and reducing pain. This approach aims to address the underlying causes of IC/BPS by restoring the integrity of the bladder lining. By delivering the biopolymer directly to the affected tissue, Glycologix seeks to minimize systemic side effects and maximize therapeutic efficacy. The technology platform has the potential to be expanded to address other soft tissue indications with similar unmet needs.
Target Audience
The primary target audience includes patients suffering from interstitial cystitis/bladder pain syndrome (IC/BPS) and the urologists who treat them.
Features
- Locally delivered biopolymers for targeted treatment of soft tissue damage
- Mimics natural proteoglycans to promote tissue protection and repair
- GLX-100: Lead compound specifically designed for interstitial cystitis/bladder pain syndrome (IC/BPS)
- High affinity to bladder tissues for sustained therapeutic effect
- Aims to restore the integrity of the bladder lining
- Potential for expansion to other soft tissue indications